Walgreens Boots Alliance Inc (WBA) Given Average Rating of “Hold” by Brokerages
Walgreens Boots Alliance Inc (NASDAQ:WBA) has been given a consensus recommendation of “Hold” by the twenty-two brokerages that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $78.31.
Several research firms have recently commented on WBA. Barclays raised their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a report on Friday, October 12th. Citigroup raised their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a report on Friday, October 12th. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Wednesday, December 12th. Loop Capital set a $82.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, December 20th. Finally, SunTrust Banks lifted their price objective on Walgreens Boots Alliance to $75.00 and gave the stock a “hold” rating in a report on Friday, October 12th.
In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $79.48, for a total value of $217,457.28. Following the completion of the sale, the director now owns 8,207 shares of the company’s stock, valued at $652,292.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Nancy M. Schlichting sold 7,050 shares of the company’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total value of $555,610.50. Following the completion of the sale, the director now directly owns 5,709 shares of the company’s stock, valued at approximately $449,926.29. The disclosure for this sale can be found here. In the last three months, insiders have sold 73,756 shares of company stock valued at $5,824,194. 15.73% of the stock is owned by company insiders.
NASDAQ:WBA traded down $0.99 during mid-day trading on Friday, reaching $71.49. 417,205 shares of the stock were exchanged, compared to its average volume of 7,338,223. The company has a market capitalization of $68.15 billion, a PE ratio of 11.86, a P/E/G ratio of 1.13 and a beta of 0.99. The company has a quick ratio of 0.36, a current ratio of 0.80 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.43 by $0.03. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The company had revenue of $33.79 billion for the quarter, compared to the consensus estimate of $33.90 billion. During the same period last year, the business posted $1.28 EPS. The company’s revenue was up 9.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Walgreens Boots Alliance will post 6.52 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th were given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date was Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: What is Net Asset Value (NAV)?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.